GIBSON DANIEL GLENN (Chief Technology Officer) received a stock award from TELESIS BIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/5/2024ACC: 0000950170-24-026452
Officer· Chief Technology Officer
Since Jun 2021
+57.24K
Net shares
Net buyer
$346.37
Total sold
0
Open market trades
0B · 0S
3
Total transactions
57.90K acquired · 656.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.40K
Price / share
—
Trade value
—
% of position
6.4%
6/22/2023
99.82K→106.22K
Common Stock
Direct
Shares
−656.00
Price / share
$0.53
Trade value
$346.37
% of position
0.6%
3/1/2024
106.22K→105.56K
Total
Net shares
+5.74K
Net value
-$346.37
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2023 | A · Award | +6.40K | — | — | 6.4% | 99.82K | 106.22K |
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −656.00 | $0.53 | $346.37 | 0.6% | 106.22K | 105.56K |
| Total | +5.74K | -$346.37 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
51.50K shares
Shares
+51.50K
Strike price
1.66
Held after
51.50K
Exercisable
—
6/22/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock51.50K shares | 6/22/2023 | A · Award | +51.50K | 1.66 | — | 51.50K |